The paclitaxel-coated balloon with a quirky design and confectionery name achieved better patency outcomes and noninferiority for safety compared with another DCB with a long track record.
Patients treated for a blocked artery in the leg were significantly more likely to have an open artery without further interventions at 12 months if they received the second-generation paclitaxel-coated balloon catheter known as the Chocolate Touch device compared with those receiving the commercially-available Lutonix drug-coated balloon catheter, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.